Interrelationship between ATP-binding cassette transporters and oxysterols

Carregando...
Imagem de Miniatura
Citações na Scopus
28
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Citação
BIOCHEMICAL PHARMACOLOGY, v.86, n.1, Special Issue, p.80-88, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
ATP-binding cassette (ABC) transporters constitute a ubiquitous superfamily of membrane proteins responsible for the translocation of several substances across membranes using the chemical energy provided by ATP hydrolysis. ABC transporters participate in many physiological and pathophysiological processes, including cholesterol and lipid transportation and multidrug resistance. Oxysterols are the products of cholesterol oxidation, formed by both enzymatic and non-enzymatic mechanisms. The role of oxysterols in cholesterol metabolism and several diseases has been widely investigated, but many questions remain to be answered. Several lines of evidence link ABC transporter functions with cholesterol and oxysterol metabolism. This review discusses ABC transporters, oxysterols, and how they interact with each other.
Palavras-chave
Oxysterols, Cholesterol, ABC transporters, Cholesterol efflux, Multiple drug resistance
Referências
  1. Albrecht C, 2007, PFLUG ARCH EUR J PHY, V453, P581, DOI 10.1007/s00424-006-0047-8
  2. Aye IL, 2009, CHEM-BIOL INTERACT, V180, P12
  3. Baldan A, 2009, J LIPID RES, V50, pS80, DOI 10.1194/jlr.R800044-JLR200
  4. Bates SE., 2003, ABC PROTEINS BACTERI, P31
  5. Batetta BPA, 1999, CELL PROLIFERAT, V32, P12
  6. Belli S, 2009, J PHARM SCI-US, V98, P1905, DOI 10.1002/jps.21558
  7. Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771
  8. Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49
  9. Bjorkhem I, 2007, LIPIDS, V42, P5, DOI 10.1007/s11745-006-1003-2
  10. Bodin K, 2001, J BIOL CHEM, V276, P38685, DOI 10.1074/jbc.M105127200
  11. Bowden K, 2008, J BIOL CHEM, V283, P18210, DOI 10.1074/jbc.M800918200
  12. Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005
  13. Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8
  14. Brown AJ, 2000, J BIOL CHEM, V275, P27627
  15. Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9
  16. BYDLOWSKI SP, 1987, AM J PHYSIOL, V252, pH14
  17. BYDLOWSKI SP, 1991, BRAZ J MED BIOL RES, V24, P421
  18. BYDLOWSKI SP, 1987, INT J VITAM NUTR RES, V57, P217
  19. Callaghan R, 2008, J CLIN PHARMACOL, V48, P365, DOI 10.1177/0091270007311568
  20. Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012
  21. Chen WSY, 2001, J BIOL CHEM, V276, P5
  22. Chisaki I, 2009, BBA-BIOMEMBRANES, V1788, P2396, DOI 10.1016/j.bbamem.2009.08.014
  23. Costet P, 2000, J BIOL CHEM, V275, P5
  24. Davis Jr W, 2004, BIOCHIM BIOPHYS ACTA, V1683, P11
  25. Dean MAR, 2001, J BIOENERG BIOMEMBR, V33, P4
  26. DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477
  27. Edwards PA, 2002, VASCUL PHARM, V38, P7
  28. ElAli A, 2012, BRAIN PATHOL, V22, P175, DOI 10.1111/j.1750-3639.2011.00517.x
  29. Elali A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001213
  30. Engel T, 2001, BIOCHEM BIOPH RES CO, V288, P5
  31. Fletcher JI HM, 2010, NAT REV CANCER, V10, P9
  32. Garrigues AEA, 2002, P NATL ACAD SCI USA, V99, P5
  33. Gayet LDG, 2005, BIOCHEMISTRY-US, V44, P10
  34. Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200
  35. Hamon Y, 2000, NAT CELL BIOL, V2, P399
  36. He SM, 2011, CURR MED CHEM, V18, P439
  37. Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200
  38. Iuliano L, 2011, CHEM PHYS LIPIDS, V164, P457, DOI 10.1016/j.chemphyslip.2011.06.006
  39. Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200
  40. Javitt NB, 2002, J LIPID RES, V43, P665
  41. Kaminski WE, 2001, BIOCHEM BIOPH RES CO, V285, P1295, DOI 10.1006/bbrc.2001.5326
  42. Kaminski WE, 2001, BIOCHEM BIOPH RES CO, V281, P249, DOI 10.1006/bbrc.2001.4305
  43. Kaminski WE, 2000, BIOCHEM BIOPH RES CO, V273, P532, DOI 10.1006/bbrc.2000.2954
  44. Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x
  45. Kilsdonk MD EP, 1995, J LIPID RES, V36, P11
  46. Kimura YKN, 2007, BIOCHEM J, V401, P8
  47. Klappe K, 2009, CHEM PHYS LIPIDS, V161, P57, DOI 10.1016/j.chemphyslip.2009.07.004
  48. Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817
  49. Kusuhara H, 2007, PFLUG ARCH EUR J PHY, V453, P735, DOI 10.1007/s00424-006-0134-x
  50. Langmann T, 2006, CLIN CHEM, V52, P310, DOI 10.1373/clinchem.2005.059774
  51. Larsson H, 2007, FREE RADICAL BIO MED, V43, P695, DOI 10.1016/j.freeradbiomed.2007.04.033
  52. Lehto M, 2008, J CELL SCI, V121, P695, DOI 10.1242/jcs.016964
  53. LINCKE CR, 1991, J BIOL CHEM, V266, P5303
  54. Luker GDNK, 1999, J BIOL CHEM, V274, P14
  55. Luoma PV, 2007, ANN MED, V39, P359, DOI 10.1080/07853890701379767
  56. Mack JT, 2006, BIOMED PHARMACOTHER, V60, P587, DOI 10.1016/j.biopha.2006.07.090
  57. Makishima M, 2005, J PHARMACOL SCI, V97, P177, DOI 10.1254/jphs.FMJ04008X4
  58. McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022
  59. Meszaros P, 2011, BIOCHEM J, V437, P483, DOI 10.1042/BJ20110427
  60. Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675
  61. Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002
  62. Nury T, 2013, BIOCHIMIE, V95, P518, DOI 10.1016/j.biochi.2012.11.013
  63. Olkkonen VM, 2012, BIOMOLECULES, V2, P76
  64. Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004
  65. Olsen BN, 2009, J AM CHEM SOC, V131, P4854, DOI 10.1021/ja8095224
  66. Piehler A, 2002, BIOCHEM BIOPH RES CO, V295, P408, DOI 10.1016/S0006-291X(02)00659-9
  67. Pohl A, 2002, BIOCHEM J, V365, P259, DOI 10.1042/BJ20011880
  68. Princen HMG, 1997, CURR PHARM DESIGN, V3, P59
  69. Quazi F, 2011, ESSAYS BIOCHEM, V50, P265, DOI [10.1042/bse0500265, 10.1042/BSE0500265]
  70. Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104
  71. Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009
  72. Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200
  73. Romsicki Y, 1998, EUR J BIOCHEM, V256, P170, DOI 10.1046/j.1432-1327.1998.2560170.x
  74. Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q
  75. Rothnie A, 2001, EUR BIOPHYS J BIOPHY, V30, P430, DOI 10.1007/s002490100156
  76. Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6
  77. Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2
  78. Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721
  79. Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
  80. Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/bse0500179, 10.1042/BSE0500179]
  81. SMITH AJ, 1994, FEBS LETT, V354, P263, DOI 10.1016/0014-5793(94)01135-4
  82. Sui H, 2012, J INT MED RES, V40, P426
  83. Tannert A, 2003, INT J ANTIMICROB AG, V22, P177, DOI 10.1016/S0924-8579(03)00217-6
  84. Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108
  85. Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200
  86. Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026
  87. Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104
  88. Troost JAN, 2004, BIOCHEM BIOPH RES CO, V316, P6
  89. Tsuruoka S, 2002, BIOCHEM BIOPH RES CO, V298, P41, DOI 10.1016/S0006-291X(02)02389-6
  90. Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200
  91. Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200
  92. Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697
  93. Vulevic B, 2001, CANCER RES, V61, P3339
  94. Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622
  95. Wang J, 2008, BIOCHEMISTRY-US, V47, P5194, DOI [10.1021/bi800292v, 10.1021/bi8OO292v]
  96. Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com
  97. Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101
  98. Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200
  99. Wenzel JJ, 2003, BIOCHEM BIOPH RES CO, V306, P1089, DOI 10.1016/S0006-291X(03)01097-0
  100. Wenzel JJ, 2007, FRONT BIOSCI, V12, P16
  101. Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10
  102. Wyles JP, 2007, EXP CELL RES, V313, P1426, DOI 10.1016/j.yexcr.2007.01.018
  103. Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200
  104. Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899
  105. Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200
  106. Yan DG, 2008, INT REV CYTOL, V265, P253, DOI 10.1016/S0074-7696(07)65007-4
  107. Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399